Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
series B
Biotech
Sparrow flits forward with $95M for midstage diabetes asset
The Oregon biotech will use the raise for a phase 2b trial of oral small molecule clofutriben in patients with Type 2 diabetes and excess cortisol.
Darren Incorvaia
Sep 24, 2025 11:22am
Fierce Biotech Fundraising Tracker: Avenzo, Sparrow & more
Sep 24, 2025 11:00am
ProVerum raises $80M for stent treatment for BPH
Aug 26, 2025 2:12pm
Apreo Health nets $130M to develop lung scaffold for emphysema
Aug 8, 2025 11:30am
Big Pharmas back Strand's $153M series B to advance mRNA drugs
Aug 7, 2025 9:20am
Nuclidium raises $99M for copper-based radiopharma pipeline
Jul 10, 2025 5:04am
